MedPath

Endoscopic Tri-Modal Imaging for the detection of early neoplasia in patients with Barrett's oesophagus in tertiary referral Centres: a randomised cross-over multicentre study

Completed
Conditions
Barrett's oesophagus, autofluorescence imaging, narrow band imaging
Cancer
Early neoplasia detection
Registration Number
ISRCTN68328077
Lead Sponsor
Academic Medical Centre (AMC) (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
84
Inclusion Criteria

1. Aged greater than 18 years
2. Prior diagnosis of BE defined as the presence of columnar lined epithelium in the tubular oesophagus with specialised intestinal metaplasia on histological investigation
3. Prior diagnosis of high-grade dysplasia or early cancer that was endoscopically inconspicuous according to the referring physician. Review of the pathology slides is not required for inclusion
4. A minimum Barrett's length of C greater than 2M greater than 2 or C less than 2M greater than 4 according to the Prague C&M classification of the endoscopic appearance of BE
5. Written informed consent

Exclusion Criteria

1. Presence of active erosive oesophagitis greater than grade A according to the Los Angles classification of erosive oesophagitis
2. Description of an endoscopically visible suspicious lesion in the Barrett's segment in the referring centre
3. Presence of conditions precluding histological sampling of the oesophagus (e.g. oesophageal varices, coagulation disorders, anticoagulant therapy)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath